|
CYAD
|
Celyad SA
|
US
|
NASDAQ
|
|
CYBN
|
Cybin Inc.
|
US
|
AMEX
|
|
CYRX
|
CryoPort, Inc.
|
US
|
NASDAQ
|
|
CYTH
|
Cyclo Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DBTX
|
Decibel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DFFN
|
Diffusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
DICE
|
DICE Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DMAC
|
DiaMedica Therapeutics Inc.
|
US
|
NASDAQ
|
|
DNA
|
Ginkgo Bioworks Holdings, Inc.
|
US
|
NYSE
|
|
DNAB
|
Social Capital Suvretta Holdings Corp. II
|
US
|
NASDAQ
|
|
DNAD
|
Social Capital Suvretta Holdings Corp. IV
|
US
|
NASDAQ
|
|
DRMA
|
Dermata Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DYAI
|
Dyadic International, Inc.
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
US
|
NASDAQ
|
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ELEV
|
Elevation Oncology, Inc.
|
US
|
NASDAQ
|
|
ELYM
|
Eliem Therapeutics, Inc
|
US
|
NASDAQ
|
|
ENOB
|
Enochian Biosciences, Inc.
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ENZ
|
Enzo Biochem, Inc.
|
US
|
NYSE
|